Bill > SB1126

This bill requires health insurance entities in Pennsylvania to provide coverage for epinephrine delivery systems, such as auto-injectors or nasal spray devices that deliver a premeasured dose of epinephrine, with specific provisions to protect consumers. The bill mandates that insurers cover at least two medically prescribed epinephrine delivery systems annually at a maximum cost of $35, regardless of the insured's deductible or other cost-sharing requirements. Additionally, the bill tasks the Attorney General with investigating epinephrine drug pricing, requiring a comprehensive public report within one year that analyzes pricing practices and offers policy recommendations to prevent overpricing. The coverage applies to various types of health plans, including high-deductible and catastrophic plans, to the maximum extent permitted by federal law. The bill aims to improve access to epinephrine delivery systems, which are critical for individuals with severe allergies who may experience life-threatening allergic reactions, by ensuring insurance coverage and promoting transparency in drug pricing. The legislation will take effect 60 days after passage and will apply to all insurance policies issued, renewed, or modified after that date.

Business and Industry

https://www.palegis.us/legislation/bills/2025/sb1126